A spotlight on pathogenesis, interactions and novel therapeutic options in NAFLD

Nat Rev Gastroenterol Hepatol. 2019 Feb;16(2):80-82. doi: 10.1038/s41575-018-0094-6.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Gastrointestinal Microbiome
  • Genetic Predisposition to Disease / genetics
  • Humans
  • Non-alcoholic Fatty Liver Disease / drug therapy
  • Non-alcoholic Fatty Liver Disease / etiology*
  • Non-alcoholic Fatty Liver Disease / genetics
  • Non-alcoholic Fatty Liver Disease / therapy